Andrew D Hershey Selected Research

Andrew D Hershey Research Topics

Disease

44	Migraine Disorders (Migraine) 01/2022 - 09/2002
36	Headache (Headaches) 01/2022 - 09/2002
8	Pain (Aches) 01/2022 - 08/2007
4	Nausea 10/2019 - 05/2010
4	Vomiting 10/2019 - 05/2010
3	Headache Disorders (Headache Syndromes) 01/2022 - 04/2012
3	Secondary Headache Disorders 01/2020 - 10/2006
3	Hyperacusis (Phonophobia) 10/2019 - 06/2012
3	Photophobia (Light Sensitivity) 10/2019 - 06/2012
3	Epilepsy (Aura) 02/2013 - 09/2002
2	Prescription Drug Overuse 05/2014 - 10/2006
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 02/2005 - 12/2004
1	Primary Headache Disorders 01/2022
1	Paroxysmal Hemicrania (Chronic Paroxysmal Hemicrania) 01/2021
1	Hyperalgesia 01/2020
1	Acute Pain 01/2018
1	Postoperative Pain 01/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Chronic Pain 01/2018
1	Weight Loss (Weight Reduction) 12/2017
1	Fatigue 12/2017
1	Body Weight (Weight, Body) 12/2017
1	Paresthesia (Dysesthesia) 12/2017
1	Neuralgia (Stump Neuralgia) 11/2016
1	Post-Traumatic Headache 11/2016
1	Seizures (Absence Seizure) 02/2013
1	Spontaneous Abortion (Miscarriage) 10/2011
1	Syncope (Fainting) 10/2011
1	Hemolytic Anemia 10/2011
1	Drug Resistant Epilepsy 02/2005
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2004

Drug/Important Bio-Agent (IBA)

15	Amitriptyline (Elavil)FDA LinkGeneric 01/2022 - 04/2005
10	Topiramate (Topamax)FDA LinkGeneric 01/2022 - 09/2002
7	Tryptamines (Triptans)IBA 10/2019 - 04/2005
5	Pain-FreeIBA 01/2021 - 08/2007
5	Nasal SpraysIBA 10/2019 - 04/2005
5	zolmitriptan (Zomig)FDA Link 10/2019 - 04/2005
4	Pharmaceutical PreparationsIBA 01/2022 - 09/2002
4	Analgesics (Analgesic Drugs)IBA 01/2021 - 04/2003
4	Type A Botulinum Toxins (Botox)FDA Link 10/2019 - 04/2012
4	sumatriptan-naproxen FDA Link 10/2019 - 10/2011
4	Valproic Acid (Depakote)FDA LinkGeneric 10/2019 - 02/2005
4	Sumatriptan (Imigran)FDA LinkGeneric 01/2016 - 04/2005
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2015 - 04/2005
3	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2019 - 05/2012
3	Ibuprofen (Motrin)FDA LinkGeneric 10/2019 - 05/2012
3	Naproxen (Naprosyn)FDA LinkGeneric 01/2016 - 10/2011
3	Dihydroergotamine (Agit)FDA LinkGeneric 01/2015 - 01/2009
3	AntiemeticsIBA 01/2015 - 05/2010
3	TabletsIBA 06/2012 - 10/2011
2	Indomethacin (Indometacin)FDA LinkGeneric 01/2022 - 01/2021
2	Caffeine (No Doz)FDA LinkGeneric 01/2020 - 01/2019
2	Propranolol (Inderal)FDA LinkGeneric 10/2019 - 01/2019
2	FlunarizineIBA 10/2019 - 01/2019
2	Nimodipine (Modus)FDA LinkGeneric 10/2019 - 01/2019
2	Cinnarizine (Cinna)IBA 10/2019 - 01/2019
2	Prochlorperazine (Compazine)FDA LinkGeneric 09/2018 - 03/2009
2	rizatriptan (Maxalt)FDA Link 01/2016 - 04/2005
2	SodiumIBA 04/2015 - 10/2011
2	Biomarkers (Surrogate Marker)IBA 02/2013 - 07/2011
2	VitaminsIBA 02/2012 - 12/2010
2	coenzyme Q10 (CoQ10)IBA 06/2011 - 01/2007
1	Metoclopramide (Reglan)FDA LinkGeneric 09/2018
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2018
1	Estrogens (Estrogen)FDA Link 01/2018
1	Hormones (Hormone)IBA 01/2018
1	Progesterone FDA LinkGeneric 01/2018
1	almotriptan (Axert)FDA Link 01/2016
1	SteroidsIBA 11/2015
1	Vasoconstrictor AgentsIBA 01/2015
1	Messenger RNA (mRNA)IBA 02/2013
1	Polyvinyl Chloride (PVC)IBA 02/2013
1	Biological ProductsIBA 10/2012
1	Cyproheptadine (Periactin)FDA Link 05/2012
1	Riboflavin (Vitamin B2)FDA LinkGeneric 12/2010
1	Anticonvulsants (Antiepileptic Drugs)IBA 04/2005
1	Antidepressive Agents (Antidepressants)IBA 04/2005
1	Nortriptyline (Aventyl)FDA LinkGeneric 04/2005
1	Carbamazepine (Tegretol)FDA LinkGeneric 02/2005
1	OligonucleotidesIBA 12/2004
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2003
1	Carnitine palmitoyl transferase 2 deficiencyIBA 05/2003
1	Carnitine (L-Carnitine)FDA LinkGeneric 05/2003

Therapy/Procedure

12	Therapeutics 01/2021 - 04/2003
3	Aftercare (After-Treatment) 01/2022 - 11/2005
1	Investigational Therapies (Experimental Therapy) 01/2019
1	Secondary Prevention 01/2018
1	Tertiary Prevention 01/2018
1	Nerve Block (Nerve Blocks) 11/2016
1	Injections 11/2016
1	Off-Label Use 05/2010